Memory-Efficient Transformer Improves Scalable Peptide Design

Rui Jiao, Xiangzhe Kong, Yinjun Jia, Yijia Zhang, Ziyi Yang, Yang Liu, Jianzhu Ma· June 25, 2026 View original

Summary

Researchers introduce MEET (Memory Efficient Equivariant Transformer), an E(3) equivariant backbone that achieves linear memory scaling and improves generation quality for full-atom peptide design, enabling more scalable and effective drug discovery.

A new E(3) equivariant backbone, the Memory Efficient Equivariant Transformer (MEET), has been developed to address the scalability challenges in target-specific peptide design. This process requires simultaneously designing both sequence and structure under complex atomic geometric constraints. Existing latent generative frameworks are effective but often limited by the geometric backbone's scalability during encoding, decoding, and denoising. MEET tackles this by maintaining coupled invariant scalar and equivariant vector feature streams, while re-engineering geometric computations around memory-efficient attention. It incorporates global coordinate aggregation, pairwise distances, and covalent bond information to enhance its capabilities. Integrated into a VAE and latent diffusion pipeline, MEET achieves linear memory scaling with atom count and significantly improves the quality of generated peptides compared to current methods. Its ability to support systematic model and data scaling on large datasets promises better binding affinity, physical validity, and sample diversity.

Why it matters

This advancement offers a more scalable and efficient computational tool for designing novel peptides, accelerating drug discovery and material science by enabling the generation of more effective and diverse molecular structures.

How to implement this in your domain

  1. 1Explore integrating MEET into existing computational drug discovery pipelines for peptide design.
  2. 2Utilize MEET for generating novel peptide candidates with improved binding affinity and physical validity.
  3. 3Apply the memory-efficient equivariant transformer principles to other molecular design or protein engineering tasks.
  4. 4Collaborate with research institutions to validate and further optimize MEET's performance on specific therapeutic targets.

Who benefits

PharmaceuticalsBiotechnologyMaterials ScienceHealthcare

Key takeaways

  • MEET enables scalable and memory-efficient full-atom peptide design.
  • It improves generation quality, binding affinity, and physical validity of peptides.
  • The E(3) equivariant transformer backbone supports systematic model and data scaling.
  • This advancement accelerates drug discovery and molecular engineering.

Original post by Rui Jiao, Xiangzhe Kong, Yinjun Jia, Yijia Zhang, Ziyi Yang, Yang Liu, Jianzhu Ma

"arXiv:2606.25006v1 Announce Type: new Abstract: Target-specific peptide design requires sequence and structure co-design under full atom geometric constraints. Latent generative frameworks offer an effective route for this problem by compressing fine grained atomic structures int…"

View on X

Originally posted by Rui Jiao, Xiangzhe Kong, Yinjun Jia, Yijia Zhang, Ziyi Yang, Yang Liu, Jianzhu Ma on X · view source

Want to go deeper?

Turn these trends into skills with Learnijoy's hands-on AI & tech courses.

Explore courses